Pharmaceutical Products Companies By Five Year Return

Five Year Return
Five Year ReturnEfficiencyMarket RiskExp Return
1MNMD Mind Medicine
904.17
 0.07 
 4.72 
 0.34 
2VKTX Viking Therapeutics
608.76
(0.05)
 5.19 
(0.25)
3MIRM Mirum Pharmaceuticals
493.48
 0.02 
 2.46 
 0.04 
4MNKD MannKind Corp
476.27
 0.19 
 2.23 
 0.42 
5SNYR SYNERGY CHC P
429.62
 0.29 
 266.54 
 78.57 
6MLTX MoonLake Immunotherapeutics
372.45
 0.05 
 3.14 
 0.17 
7VERA Vera Therapeutics
311.48
 0.10 
 3.83 
 0.38 
8VCEL Vericel Corp Ord
212.15
 0.08 
 3.09 
 0.25 
9MDGL Madrigal Pharmaceuticals
211.88
 0.11 
 4.60 
 0.50 
10MRUS Merus BV
192.08
(0.12)
 2.11 
(0.26)
11DVAX Dynavax Technologies
126.35
 0.06 
 2.50 
 0.16 
12MRNA Moderna
82.48
(0.35)
 3.26 
(1.14)
13IZTC Invizyne Technologies Common
60.39
 1.05 
 7.51 
 7.88 
14CYCCP Cyclacel Pharmaceuticals
53.88
(0.07)
 4.33 
(0.32)
15MREO Mereo BioPharma Group
44.22
(0.11)
 3.45 
(0.38)
16DNLI Denali Therapeutics
41.4
(0.01)
 3.46 
(0.03)
17DMAC DiaMedica Therapeutics
29.54
 0.03 
 2.67 
 0.08 
18BHST BioHarvest Sciences Common
18DRUG Bright Minds Biosciences
21.07
 0.14 
 127.81 
 18.17 
19GRCE Grace Therapeutics,
6.98
 0.13 
 4.71 
 0.60 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions. Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.